Brainomix secures an extension of its Series C financing, raising £4.8 million ($6.5 million) to support U.S. expansion, totaling £18.8 million ($25.4 million). The round was led by Parkwalk and Hostplus with participation from Modi Ventures.

Brainomix has raised £14M in Series C funding led by Parkwalk Advisors and the Boehringer Ingelheim Venture Fund. The funds will be used to accelerate the company's commercial expansion into the US.

Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe

Oxford Medtech Brainomix Raises £16M To Expand Ai Tool Beyond Stroke Diagnosis

Brainomix specializes in the creation of AI-powered software solutions to enable precision medicine for enhanced treatment decisions in stroke and lung fibrosis. With origins as a spinout from the University of Oxford, it is now expanding at a commercial-stage with offices in the UK, Ireland and the USA, and operations in more than 20 countries.

Brainomix

Funding history

Recent signals